Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Cellbxhealth (CLBX) Share Price

Price 0.875p on 07-05-2026 at 10:34:48
Change 0.025p 2.94%
Buy 0.95p
Sell 0.80p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Buy 560,000.00 at 0.90p
Day's Volume: 925,017
Last Close: 0.85p
Open: 0.85p
ISIN: GB0034330679
Day's Range 0.85p - 0.875p
52wk Range: 0.85p - 11.00p
Market Capitalisation: £17.04m
VWAP: 0.89634p
Shares in Issue: 1.95b

Cellbxhealth (CLBX) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 560,000 0.90p Ordinary
 11:34:47 - 07-May-26
Buy* 55,218 0.894p Ordinary
 11:22:20 - 07-May-26
Buy* 24,000 0.866p Ordinary
 10:43:37 - 07-May-26
Buy* 110,794 0.894p Ordinary
 10:39:29 - 07-May-26
Buy* 25,000 0.894p Ordinary
 10:00:08 - 07-May-26
Buy* 27,518 0.894p Ordinary
 09:35:11 - 07-May-26
Buy* 2,665 0.865p Ordinary
 09:02:29 - 07-May-26
Buy* 8,000 0.866p Ordinary
 08:59:00 - 07-May-26
Buy* 162 0.90p Ordinary
 08:31:08 - 07-May-26
Buy* 111,660 0.892p Ordinary
 08:01:45 - 07-May-26
See more Cellbxhealth trades

Cellbxhealth (CLBX) Share Price History

Time period:
to
Date Open High Low Close Volume
6th May 2026 (Wed) 0.90 0.90 0.85 0.85 1,551,072
5th May 2026 (Tue) 0.90 0.90 0.90 0.90 735,161
4th May 2026 (Mon) 0.90 0.90 0.90 0.90 0
1st May 2026 (Fri) 0.90 0.90 0.90 0.90 1,582,939
30th Apr 2026 (Thu) 0.925 0.925 0.90 0.90 7,249,074
29th Apr 2026 (Wed) 0.925 0.95 0.925 0.925 5,334,580
28th Apr 2026 (Tue) 0.95 0.90 0.90 0.90 647,832
27th Apr 2026 (Mon) 0.975 0.975 0.95 0.95 1,704,571
24th Apr 2026 (Fri) 0.975 0.975 0.975 0.975 1,005,912
23rd Apr 2026 (Thu) 0.975 0.975 0.975 0.975 1,689,756
22nd Apr 2026 (Wed) 0.975 0.975 0.975 0.975 390,381
21st Apr 2026 (Tue) 0.975 0.99 0.975 0.975 1,726,329
20th Apr 2026 (Mon) 0.95 0.975 0.95 0.975 13,788,033
17th Apr 2026 (Fri) 0.90 0.90 0.90 0.90 3,895,867
16th Apr 2026 (Thu) 0.90 0.90 0.90 0.90 463,032
15th Apr 2026 (Wed) 0.90 0.90 0.90 0.90 1,551,380
14th Apr 2026 (Tue) 0.90 0.90 0.875 0.90 2,733,430
13th Apr 2026 (Mon) 0.90 0.90 0.90 0.90 2,400,350
10th Apr 2026 (Fri) 0.90 0.90 0.875 0.90 4,478,611
9th Apr 2026 (Thu) 0.90 0.90 0.90 0.90 78,191
8th Apr 2026 (Wed) 0.90 0.90 0.875 0.90 1,924,674
7th Apr 2026 (Tue) 0.90 0.90 0.90 0.90 737,151
See more Cellbxhealth price history

Cellbxhealth (CLBX) Regulatory News

Date Source Headline
30th Apr 2026 7:00 am RNS Confirmation of Q1 trading update
20th Apr 2026 7:00 am RNS Research Collaboration with The Royal Marsden
16th Apr 2026 5:39 pm RNS Board changes - Replacement
13th Feb 2026 7:00 am RNS Aligning Regulatory Approach with Commercial Needs
16th Jan 2026 7:00 am RNS Preliminary Fourth Quarter 2025 Financial Results
12th Jan 2026 7:00 am RNS Board changes
23rd Dec 2025 9:15 am RNS Holding(s) in Company
23rd Dec 2025 9:15 am RNS Holding(s) in Company
19th Dec 2025 5:51 pm RNS PDMR Dealing and ESOT Share Purchase
19th Dec 2025 5:51 pm RNS PDMR Dealing and ESOT Share Purchase
See more Cellbxhealth regulatory news

Cellbxhealth (CLBX) Share News

TRADING UPDATES: Metir distribution deals in Middle East, Africa, Asia

20th Apr 2026 18:29

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

IN BRIEF: Cellbxhealth eyes cost savings as revenue falls in 2025

16th Jan 2026 14:02

Cellbxhealth PLC - Guildford, England-based liquid biopsy company, formerly called Angle PLC - Expects to report 2025 revenue of GBP1.4 million, down 51% from GBP2.9 million in 2024. The firm highlights it first expected revenue of GBP1.6 million for 2025, however a few sales contracts were deferred into the first quarter of 2026. Cash at December 31 was GBP7.3 million, down 30% from GBP10.4 million a year ago. Chief Executive Officer Peter Collins says: "The company remains on track with the execution of its organisational restructure and delivery of associated cost-saving measures. With management focused on refining the company's business strategy, securing funding and implementing the restructure during the fourth quarter of 2025, some sales contracts, with an aggregate value of approximately GBP200,000, were deferred into the first quarter of 2026." The company will publish 2025 results in June. Read More

EARNINGS AND TRADING: IntelliAM AI fundraise; Synectics extends deal

24th Nov 2025 20:38

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

TRADING UPDATES: CVS sales climb; Time to Act flags division progress

18th Nov 2025 12:42

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

AIM WINNERS & LOSERS: CelLBxHealth rises on Qiagen deal

18th Nov 2025 09:29

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday. Read More

See more Cellbxhealth news
FTSE 100 Latest
Value10,378.13
Change-60.53

Login to your account

Forgot Password?

Not Registered